Optimized Scintigraphic Evaluation of Infection and Inflammation: Role of Single-Photon Emission Computed Tomography/Computed Tomography Fusion Imaging

Seminars in Nuclear Medicine

Volumn 36, Issue 4, 2006, Pages 295-311

  Bunyaviroch, Tira ^a   Aggarwal, Atul ^a   Oates, M Elizabeth ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPROMAB PENDETIDE IN 111; CIPROFLOXACIN TC 99M; ETIDRONIC ACID TC 99M; FANOLESOMAB TC 99M; GALLIUM CITRATE GA 67; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; INDIUM 111; MEDRONATE TECHNETIUM TC 99M; PENTETREOTIDE IN 111; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; TECHNETIUM SULFUR COLLOID TC 99M; TETROFOSMIN TC 99M; THALIUM 201; UNCLASSIFIED DRUG;

CLINICAL TRIAL; COMPUTER; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; EVALUATION; HUMAN; INFECTION; INFLAMMATION; LEUKOCYTE; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EQUIPMENT DESIGN; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INFECTION; INFLAMMATION; SUBTRACTION TECHNIQUE; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33748046158     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2006.05.004     Document Type: Review

References (56)

1. McCall M.S., Sutherland D.A., Eisentraut A.M., et al. The tagging of leukemic leukocytes with radioactive chromium and measurement of the in vivo cell survival. J Lab Clin Med 45 (1955) 717-724
2. Athens J.W., Mauer A.M., Ashenbrucker H., et al. Leukokinetic studies. I. A method for labeling leukocytes with diisopropyl-fluorophosphate (DFP32). Blood 14 (1959) 303-333
3. Lee V.W., Antonacci V., Tilak S., et al. Intracranial mass lesions: sequential thallium and gallium scintigraphy in patients with AIDS. Radiology 211 (1999) 507-512
4. Love C., and Palestro C.J. Radionuclide imaging of infection. J Nucl Med Technol 32 (2004) 47-57
5. 99mTc-ciprofloxacin. Hepatogastroenterology 52 (2005) 491-495
6. 99mTc-ciprofloxacin planar and tomographic imaging for the diagnosis of infection in the postoperative spine: experience in 48 patients. Eur J Nucl Med Mol Imaging 31 (2004) 233-239
7. 99mTc ciprofloxacin imaging for the diagnosis of infection in the postoperative spine. Nucl Med Commun 25 (2004) 277-283
8. 99m ciprofloxacin (Infecton) imaging in suspected orthopaedic infection: a comparison with sequential bone/gallium imaging. Eur J Nucl Med 28 (2001) 822-830
9. Bleeker-Rovers C.P., Vos F.J., Wanten G.J., et al. 18F-FDG PET in detecting metastatic infectious disease. J Nucl Med 46 (2005) 2014-2019
10. Love C., Tomas M.B., Tronco G.G., et al. FDG PET of infection and inflammation. Radiographics 25 (2005) 1357-1368
11. Hoffer P. Gallium: mechanisms. J Nucl Med 21 (1980) 282-285
12. Hara T. On the binding of gallium to transferrin. Int J Nucl Med Biol 1 (1974) 152-154
13. Aulbert E., Gebhardt A., Schulz E., et al. Mechanism of 67Ga accumulation in normal rat liver lysosomes. Nuklearmedizin 15 (1976) 185-194
14. Hoffer P.B., Huberty J., and Khayam-Bashi H. The association of Ga-67 and lactoferrin. J Nucl Med 18 (1977) 713-717
15. Weiner R., Hoffer P.B., and Thakur M.L. Lactoferrin: its role as a Ga-67-binding protein in polymorphonuclear leukocytes. J Nucl Med 22 (1981) 32-37
16. Muller G., and Raymond K.N. Specificity and mechanism of ferrioxamine-mediated iron transport in Streptomyces pilosus. J Bacteriol 160 (1984) 304-312
17. Tsan M.F. Mechanism of gallium-67 accumulation in inflammatory lesions. J Nucl Med 26 (1985) 88-92
18. Newman R.D., and McAfee J.G. Gallium-67 imaging in infection. In: Sandler M.P., Coleman R.E., Patton J.A., et al. (Eds). Diagnostic Nuclear Medicine. (ed 4) (2004), Lippincott, Williams, and Wilkins, Philadelphia 1205-1217
19. Dhawan V.M., Sziklas J.J., and Spencer R.P. Localization of Ga-67 in inflammations in the absence of circulating polymorphonuclear leukocytes. J Nucl Med 19 (1978) 292-294
20. McAfee J.G., and Thakur M.L. Survey of radioactive agents for in vitro labeling of phagocytic leukocytes.I. Soluble agents. J Nucl Med 17 (1976) 480-487
21. McAfee J.G., and Thakur M.L. Survey of radioactive agents for in vitro labeling of phagocytic leukocytes. II. Particles J Nucl Med 17 (1976) 488-492
22. Palestro C.J., and Torres M.A. Radionuclide imaging of nonosseous infection. Q J Nucl Med 43 (1999) 46-60
23. 99mTc-HM-PAO for leukocyte labeling-experimental comparison with 111In oxine in dogs. Eur J Nucl Med 13 (1987) 353-357
24. 99m HM-PAO and indium-111 tropolonate. J Nucl Med 29 (1988) 1246-1251
25. Peters A.M., Roddie M.E., Danpure H.J., et al. 99Tcm-HMPAO labelled leucocytes: comparison with 111In-tropolonate labelled granulocytes. Nucl Med Commun 9 (1988) 449-463
26. 99m-HM-PAO leukocytes with indium-111-oxine leukocytes for localizing intraabdominal sepsis. J Nucl Med 31 (1990) 311-315
27. Thakur M.L., Coleman R.E., and Welch M.J. Indium-111-labeled leukocytes for the localization of abscesses: preparation, analysis, tissue distribution, and comparison with gallium-67 citrate in dogs. J Lab Clin Med 89 (1977) 217-228
28. Coleman R.E., and Datz F.L. Detection of inflammatory disease with radiolabeled cells. In: Sandler M.P., Coleman R.E., Patton J.A., et al. (Eds). Diagnostic Nuclear Medicine. (ed 4) (2004), Lippincott, Williams, and Wilkins, Philadelphia 1219-1234
29. Sfakianakis G.N., Al-Sheikh W., Heal A., et al. Comparisons of scintigraphy with In-111 leukocytes and Ga-67 in the diagnosis of occult sepsis. J Nucl Med 23 (1982) 618-626
30. 99mCc and a scintillation camera. J Nucl Med 18 (1977) 373-380
31. Phelps M.E. What is the purpose of emission computed tomography in nuclear medicine. J Nucl Med 18 (1977) 399-402
32. New P.F., Scott W.R., Schnur J.A., et al. Computed tomography with the EMI scanner in the diagnosis of primary and metastatic intracranial neoplasms. Radiology 114 (1975) 75-87
33. Baker Jr. H.L., Campbell J.K., Houser O.W., et al. Early experience with the EMI scanner for study of the brain. Radiology 116 (1975) 327-333
34. Treves S.T., Mitchell K.D., and Habboush I.H. Three dimensional image alignment, registration and fusion. Q J Nucl Med 42 (1998) 83-92
35. Mongioj V., Brusa A., Loi G., et al. Accuracy evaluation of fusion of CT, MR, and spect images using commercially available software packages (SRS PLATO and IFS). Int J Radiat Oncol Biol Phys 43 (1999) 227-234
36. Schillaci O., and Simonetti G. Fusion imaging in nuclear medicine-applications of dual-modality systems in oncology. Cancer Biother Radiopharm 19 (2004) 1-10
37. Townsend D.W., and Cherry S.R. Combining anatomy and function: the path to true image fusion. Eur Radiol 11 (2001) 1968-1974
38. Swayne L.C. Computer-assisted fusion of single-photon emission tomographic and computed tomographic images. Evaluation in complicated inflammatory disease. Invest Radiol 27 (1992) 78-83
39. Horger M., Eschmann S.M., Pfannenberg C., et al. The value of SPET/CT in chronic osteomyelitis. Eur J Nucl Med Mol Imaging 30 (2003) 1665-1673
40. Bar-Shalom R., Yefremov N., Guralnik L., et al. SPECT/CT using 67Ga and 111In-labeled leukocyte scintigraphy for diagnosis of infection. J Nucl Med 47 (2006) 587-594
41. Utsunomiya D., Shiraishi S., Imuta M., et al. Added value of SPECT/CT fusion in assessing suspected bone metastasis: comparison with scintigraphy alone and nonfused scintigraphy and CT. Radiology 238 (2006) 264-271
42. 99m] tetrofosmin. Cancer Biother Radiopharm 21 (2006) 41-48
43. Kramer E.L., Noz M.E., Sanger J.J., et al. CT-SPECT fusion to correlate radiolabeled monoclonal antibody uptake with abdominal CT findings. Radiology 172 (1989) 861-865
44. Even-Sapir E., Keidar Z., Sachs J., et al. The new technology of combined transmission and emission tomography in evaluation of endocrine neoplasms. J Nucl Med 42 (2001) 998-1004
45. Yamamoto Y., Nishiyama Y., Monden T., et al. Clinical usefulness of fusion of 131I SPECT and CT images in patients with differentiated thyroid carcinoma. J Nucl Med 44 (2003) 1905-1910
46. Ruf J., Lehmkuhl L., Bertram H., et al. Impact of SPECT and integrated low-dose CT after radioiodine therapy on the management of patients with thyroid carcinoma. Nucl Med Commun 25 (2004) 1177-1182
47. Pfannenberg A.C., Eschmann S.M., Horger M., et al. Benefit of anatomical-functional image fusion in the diagnostic work-up of neuroendocrine neoplasms. Eur J Nucl Med Mol Imaging 30 (2003) 835-843
48. Krausz Y., Keidar Z., Kogan I., et al. SPECT/CT hybrid imaging with 111In-pentetreotide in assessment of neuroendocrine tumours. Clin Endocrinol (Oxf) 59 (2003) 565-573
49. Amthauer H., Denecke T., Rohlfing T., et al. Value of image fusion using single photon emission computed tomography with integrated low dose computed tomography in comparison with a retrospective voxel-based method in neuroendocrine tumours. Eur Radiol 15 (2005) 1456-1462
50. Profanter C., Prommegger R., Gabriel M., et al. Computed axial tomography-MIBI image fusion for preoperative localization in primary hyperparathyroidism. Am J Surg 187 (2004) 383-387
51. Schillaci O. Functional-anatomical image fusion in neuroendocrine tumors. Cancer Biol Radiopharm 19 (2004) 129-134
52. Schettino C.J., Kramer E.L., Noz M.E., et al. Impact of fusion of indium-111 capromab pendetide volume data sets with those from MRI or CT in patients with recurrent prostate cancer. Am J Roentgenol 183 (2004) 519-524
53. Slomka P.J. Software approach to merging molecular with anatomic information. J Nucl Med 45 Suppl 1 (2004) 36S-45S
54. Keidar Z., Israel O., and Krausz Y. SPECT/CT in tumor imaging: technical aspects and clinical applications. Semin Nucl Med 33 (2003) 205-218
55. Butler T., Hirsch L.J., and Claassen J. The hazards of lack of co-registration of ictal brain SPECT with MRI: A case report of sinusitis mimicking a brainstem seizure focus. BMC Nucl Med 4 (2004) 2
56. Wahl R.L. Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT. J Nucl Med 41 suppl 1 (2004) 82S-95S